As a major component of the TME, CD4+ T cells may attack tumor cells directly through cytolytic responses or indirectly through regulating other lymphocytes, such as strengthening B cell and cytotoxic T cells (CTLs) responses [43, 44]. This evidence concerns the gene CD4 and neoplasm.